Mammalian

© GettyImages/Monty Rakusen

Lonza: N-1 perfusion capability enables increased process titers

By Jane Byrne

The biopharma sector has seen recent advancements in process intensification, especially in relation to upstream processing, with the technology employed aimed at increasing drug output. One of the quickest and simplest ways to achieve process intensification...